Liens UNIL

FR EN

Unisciences

Vous êtes ici: UNIL > Unisciences

Recherche
- Recherche
- Afficher les données
  de à

Pierre Baumann

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil

597 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ...

2024

Nöropsikofarmakolojide Terapötik İla ç İzlemi İ çin Ortak Görü ş Kılavuzu: 2017 G üncellemesi

Hiemke C., Bergemann N., Clement H. W., Conca A., Deckert J., Domschke K., Eckermann G., Egberts K., Gerlach M., Greiner C. et al., 2024. 81, ğlığı Derneği, Bayt Publications.

[URN][serval:BIB_5D7511DD93AF]

TDM, Arzneimitteltherapie-Sicherheit und Pharmakovigilanz

Baumann Pierre, Schoretsanitis Georgios, 2024. Info Neurologie & Psychiatrie, 22 (1) pp. 26-27.

[URN][serval:BIB_86EAACF7C311]

2023

Switching antipsychotics to partial dopamine D2-agonists in individuals affected by schizophrenia: a narrative review.

Baumann P., Bauknecht P., Kuzin M., Schoretsanitis G., 2023/11. International journal of psychiatry in clinical practice, 27 (4) pp. 367-384. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_58F657E99921]

Citalopram in vitro metabolism in a Beagle dog: A role for CYP2D15 in the production of toxic didesmethylcitalopram?

Rochat B., Paus E., Maitre C., Baumann P., 2023/04. Veterinarni medicina, 68 (4) pp. 135-144. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_47543DE24198]

Behind the Curtain: Therapeutic Drug Monitoring of Psychotropic Drugs from a Laboratory Analytical Perspective

Scherf-Clavel Maike, Baumann Pierre, Hart Xenia M., Schneider Heike, Schoretsanitis Georgios, Steimer Werner, Zernig Gerald, Zurek Gabriela, 2023/03/16. Therapeutic Drug Monitoring, Publish Ahead of Print.

[DOI][Pmid][serval:BIB_A7C0868C9318]

2022

Pharmacotherapy of Personality Disorders

Baumann Pierre, Herpertz Sabine C., 2022. dans NeuroPsychopharmacotherapy, Riederer, P. Laux, G. Nagatsu T. Le W. Riederer C..

[DOI][serval:BIB_AE0AD607DB08]

Tests pharmacogénétiques et surveillance thérapeutique des médicaments: pertinence clinique dans les troubles bipolaires

Kuzin Maxim, Baumann Pierre, 2022. Leading Opinions Neurologie & Psychiatrie 1 pp. 6-11.

[serval:BIB_4215918E6C45]

2021

Arzneimittelsicherheit bei bipolaren Störungen: Therapeutisches Drug Monitoring und pharmakogenetische Aspekte

Baumann Pierre, Kuzin Maxim, 2021/12/21. brainMAG.

[serval:BIB_5B0FEC14AA8D]

Traitement des troubles bipolaires. Pharmacovigilance. Monitoring thérapeutique des médicaments et aspects pharmacogénétiques

Baumann Pierre, Kuzin Maxim, 2021/11/21. médMAG, 1 (2) pp. 46-51.

[serval:BIB_185DACFA7C69]

Gerd Laux, Walter E. Müller (Herausgeber): Psychopharmakologie und Psychopharmakotherapie kompakt. Weiterbildungs-Curriculum zum Facharzt für Psychiatrie und Psychotherapie

Baumann Pierre, 2021/10/20. Swiss Archives of Neurology, Psychiatry and Psychotherapy, 172.

[URN][DOI][serval:BIB_3D3C1CEC3362]

Prescription of St John's Wort extracts: clinical risks due to differences in their hyperforin content

BAUMANN Pierre, 2021/10. Minerva Psychiatry, 62 (3) pp. 198-9.

[DOI][WoS][serval:BIB_2CF73438A6AD]

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

Eap C.B., Gründer G., Baumann P., Ansermot N., Conca A., Corruble E., Crettol S., Dahl M.L., de Leon J., Greiner C. et al., 2021/10. The world journal of biological psychiatry, 22 (8) pp. 561-628. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_6FD14CC75A02]

Plasma Concentrations and Cardiovascular Effects of Citalopram Enantiomers After Oral Versus Infusion Citalopram Therapy in Dextromethorphan-Mephenytoin-Phenotyped Patients With Major Depression.

Baumann P., Bertschy G., Ramseier F., Nil R., 2021/06/01. Therapeutic drug monitoring, 43 (3) pp. 436-442. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8E9409E4FB71]

Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs.

Schoretsanitis G., Baumann P., Conca A., Dietmaier O., Giupponi G., Gründer G., Hahn M., Hart X., Havemann-Reinecke U., Hefner G. et al., 2021/02/01. Therapeutic drug monitoring, 43 (1) pp. 79-102. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_6D80B8C7E8D5]

Agonistes partiels de la dopamine D2: Pharmacologie et signification clinique

Baumann Pierre, Wagner Martin, 2021. Info Neurologie & Psychiatrie.

[serval:BIB_FAB339FE15E0]

Die Rezeptvalidierung bei psychiatrischen Patienten. Plädoyer für eine gestärkte Kommunikation zwischen Psychiatrie und Offizin

Stämpfli Dominik, Baumann Pierre, 2021. pharmaJournal 2 pp. 18-20.

[serval:BIB_29D32372D521]

La validation d'ordonnance chez le patient psychiatrique. Plaidoyer pour une meilleure communication entre psychiatres et pharmaciens

Stämpfli Dominik, Baumann Pierre, 2021. pharmaJournal 2 pp. 18-20.

[serval:BIB_8D67F5D52FC4]

Les substances psychotropes en Suisse

Baumann Pierre, Eich Philipp, Hasler Gregor, Nick Beat, 2021., Janssen Neuroscience.

[serval:BIB_D4B11EAF1BA0]

Partielle D2-Dopamin-Agonisten: Pharmakologie und klinische Bedeutung

Baumann Pierre, Wagner Martin, 2021. Info Neurologie & Psychiatrie, 19 (6) pp. 12-23.

[serval:BIB_599D4CE8E952]

Pharmakogenetische Tests und therapeutisches Drug Monitoring: klinische Relevanz bei bipolaren Störungen

Kuzin Maxim, Baumann Pierre, 2021. Leading Opinions Neurologie & Psychiatrie 6 pp. 6-11.

[serval:BIB_EF8FFF746B04]

Psychopharmaka in der Schweiz

Baumann Pierre, Eich Philipp, Hasler Gregor, Nick Beat, 2021., Janssen Neuroscience.

[serval:BIB_03C9DD6E45F6]

Θεραπευτική παρακολούθηση φαρμάκων στην Ψυχιατρική και στη Νευρολογία Κατευθυντήριες Οδηγίες στη Νευροψυχοφαρμακολογία, επικαιροποίηση 2017

Schoretsanitis Georg, Pallis E.G., Paulzen Michael, Unterecker Stefan, Schwarz Markus, Conca Andreas, Zernig Gerald, Gründer Gerd, Haen Eckardt, Baumann Pierre et al., 2021. Archives of hellenic medicine, 38 (6) pp. 817-832.

[serval:BIB_117F32710678]

2020

Guía de consenso de expertos para la monitorización terapéutica de drogas en neuropsicofarmacología

López-Jaramillo Carlos, Díaz-Zuluaga Ana M., de Leon Jose, Schoretsanitis Georgios, Paulzen Michael, Unterecker Stefan, Schwarz Markus, Conca Andreas, Zernig Gerald, Gründer Gerhard et al., 2020/09. Psiquiatría Biológica, 27 (3) pp. 83-95.

[DOI][serval:BIB_BA338CF4A22C]

Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie.

Schoretsanitis G., Kane J.M., Correll C.U., Marder S.R., Citrome L., Newcomer J.W., Robinson D.G., Goff D.C., Kelly D.L., Freudenreich O. et al., 2020/05/19. The Journal of clinical psychiatry, 81 (3) pp. 19cs13169. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B506EE76FAFC]

The effect of perazine on the CYP2D6 and CYP2C19 phenotypes as measured by the dextromethorphan and mephenytoin tests in psychiatric patients.

Baumann Pierre, Eap Chin B., Gastpar Markus, 2020/05. Basic & clinical pharmacology & toxicology, 126 (5) pp. 444-447. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_D5D86F76E23B]

Depression: Neue Wege der antidepressiven Behandlung (Editorial)

Baumann P.ierre, 2020. Info Neurologie & Psychiatrie, 18 (3) p. 1.

[URN][serval:BIB_B5AA9FBF4678]

Personalisierung der Pharmakotherapie bei Depression. Therapeutisches Drug-Monitoring und Implementierung der Pharmakogenomik

Baumann Pierre, Jetter Alexander, 2020. Ars Medici 11+12 pp. 364-371.

[URN][serval:BIB_BA1809161F13]

Phytotherapie bei Depression. Geringes Interaktionsrisiko mit hyperforinarmem Johanniskraut

Baumann Pierre, 2020. Info Neurologie & Psychiatrie, 18 (3) pp. 20 - 23.

[URN][serval:BIB_E6C28918269D]

Phytothérapie de la dépression. Risque minime d'interaction avec l'hypéricum faible en teneur d'hyperforine

Baumann Pierre, 2020. Info Neurologie & Psychiatrie, 18 (3) pp. 20-23.

[URN][serval:BIB_69BCF23BD5F7]

Psychiatrische Patienten fragen ihren Arzt und Apotheker - wie kann die ambulante Versorgung optimiert werden?

Baumann Pierre, Hahn Martina, Roll Sabine .C., Stämpfli Dominik, 2020. Psychopharmakotherapie, 27 (6) pp. 270 - 277.

[serval:BIB_53A833A763A6]

Slow-drop infusion versus oral administration of citalopram: Comparison of plasma concentrations of the enantiomers of citalopram and its metabolites

Baumann Pierre, Nil Rico, 2020. Pharmacopsychiatry, 53 p. 140.

[serval:BIB_ACC8D48ABC4B]

2019

Therapeutisches Drug-Monitoring in der Neuropsychopharmakologie : Zusammenfassung der Konsensusleitlinien 2017 der TDM-Arbeitsgruppe der AGNP [Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP]

Unterecker Stefan, Hefner Gudrun, Baumann Pierre, Gründer Gerd, Bergemann Niels, Clement Hans Willi, Conca Andreas, Deckert Jürgen, Domschke Katharina, Eckermann Gabriel et al., 2019/05. Der Nervenarzt, 90 (5) pp. 463-471. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_CEA996B2B066]

About the Misleading Use of Stereodescriptors in Labeling the Stereoisomers of Milnacipran and Levomilnacipran.

Baumann P., 2019. Journal of clinical psychopharmacology, 39 (6) pp. 673-674. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C1E7FFA712AF]

Clinical Psychopharmacology in Switzerland.

Baumann Pierre, 2019. Journal of clinical psychopharmacology, 39 (1) pp. 5-8. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9706F62C65BF]

Les nouvelles recommandations du groupe AGNP-TDM

Baumann Pierre, Gründer Gerd, Bergemann Niels, Clement Hans Willi, Conca Andreas, Domschke Katharina, Eckermann Gabriel, Egberts Karin, Gerlach Manfred, Silva Gracia Margarete et al., 2019. InFo Neurologie & Psychiatrie, 17 (1) pp. 20-24.

[serval:BIB_7D357FC52738]

Neue Konsensusleitlinien der TDM-Arbeitsgruppe der AGNP

[URN][serval:BIB_D136C2439133]

2018

Konsensus-leitlinien für therapeutisches Drug-Monitoring in der Neuropsychopharmakologie: Update 2017

Hefner Gudrun, Laux Gerd, Baumann Pierre, Bergemann Niels, Clement Hans-Willi, Conca Andreas, Deckert Jürgen, Domschke Katharina, Eckermann Gabriel, Egberts Karin et al., 2018/06/03. Psychopharmakotherapie, 25 pp. 92-140.

[serval:BIB_BCC854C7E02F]

TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>.

Schoretsanitis Georg, Paulzen Michael, Unterecker Stefan, Schwarz Markus J., Conca Andreas, Zernig Gerald, Gründer Gerhard, Haen Ekkehard, Baumann Pierre, Bergemann Niels et al., 2018/04. The world journal of biological psychiatry, 19 (3) pp. 162-174. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9D1041ED4C31]

Implementation of Therapeutic Drug Monitoring and Pharmacogenetic Tests in Psychiatry: How About ABCB1?

Baumann Pierre, 2018/03/13. Journal of Bioequivalence and Bioavailability, 10 (2) pp. 371-372.

[URN][serval:BIB_1E1ED7155148]

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.

Hiemke Christoph, Bergemann Niels, Clement Hans-Willi, Conca Andreas, Deckert Jürgen, Domschke Katharina, Eckermann Gabriel, Egberts Karin, Gerlach Manfred, Greiner Christine et al., 2018/01. Pharmacopsychiatry, 51 (1-02) pp. 9-62. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_4965E3E471A7]

Implémentation de la pharmacogénomique en psychiatrie

Baumann Pierre, 2018. Info Neurologie und Psychiatrie, 16 (2) pp. 37-38.

[serval:BIB_71B3E7808541]

Training in Psychopharmacology- Pharmacopsychiatry for Residents in Psychiatry

Baumann Pierre, 2018. dans Education about Mental Health and Illness, Springer.

[serval:BIB_B4B626755049]

2017

Creation of the Swiss group of Pharmacogenomics and personalised Therapy (SPT).

Amstutz Ursula, Mlakar Vlad, Huezo-Dias Curtis Patricia, Samer Caroline, Baumann Pierre, Bühlmann Roland P., Meier-Abt Peter, Meyer Urs .A., van Schaik Ron H.N., Ansari Marc et al., 2017/12/20. Drug metabolism and personalized therapy, 32 (4) pp. 173-174. Peer-reviewed.

[DOI][Pmid][serval:BIB_B2395D76FAB8]

Pharmacogénomique et thérapie personnalisée

Baumann Pierre, Amstutz Ursula, Bühlmann Roland .P., Meier-Abt Peter, Meyer Urs A., Samer Caroline, Ansari Marc, 2017/09/06. Revue medicale suisse, 13 (573) pp. 1544-1545. Peer-reviewed.

[Pmid][serval:BIB_813E0D2AED3F]

A proposal for a psychopharmacology-pharmacotherapy catalogue of learning objectives and a curriculum in Europe.

Baumann Pierre, Spies Marie, Möller Hans-Jürgen, Kasper Siegfried, Bitter Istvan, Laux Gerd, 2017/02. The world journal of biological psychiatry, 18 (1) pp. 29-38. Peer-reviewed.

[URN][DOI][Pmid][serval:BIB_E2A992624392]

Editorial: Psychopharmakologie-Pharmakopsychiatrie

Baumann Pierre, 2017. Info Neurologie & Psychiatrie, 15 (6) p. 20.

[serval:BIB_C0E2B81A5112]

Grundlagen und praktische Hinweise für pharmakogenetische Tests

Baumann Pierre, Amstutz Ursula, Jetter Alexander, Samer Caroline, Ansari Marc, 2017. InFo NEUROLOGIE & PSYCHIATRIE, 15 (6) pp. 21-30.

[serval:BIB_089A58501EB9]

Notions de base et aspects pratiques à propos de tests pharmacogénétiques dans le cadre d'une psychopharmacothérapie

Baumann Pierre, Amstutz Ursula, Jetter Alexander, Samer Caroline, Ansari Marc, 2017. Info Neurologie und Psychiatrie, 15 (6) pp. NA.

[serval:BIB_C2B48CC0CA19]

Personalisierte Therapie bei Psychopharmaka: Grundlagen und praktische Hinweise für pharmakogenetische Tests

Baumann Pierre, Amstutz Ursula, Jetter Alexander, Samer Caroline, Ansari Marc, 2017. Info Neurologie & Psychiatrie, 15 (6) pp. 21-32.

[serval:BIB_0F17BF67B74C]

Pharmacogénomique et thérapie personnalisée: Notions de base et aspects pratiques à propos de tests pharmacogénétiques dans le cadre d'une psychopharmacothérapie

Baumann Pierre, Amstutz Ursula, Jetter Alexander, Samer Caroline, Ansari Marc, 2017. Info Neurologie & Psychiatrie, 15 (6) pp. 21 - 32.

[serval:BIB_D551C4E154BE]

Psychopharmacology curriculum for psychiatric residents [Konzeptuelle Vorschläge zur Weiterbildung in Psychopharmakologie]

Laux Gerd, Baumann Pierre, Möller Hans-Jürgen, 2017. Die Psychiatrie - Grundlagen und Perspektiven, 14 (1) pp. 21-27.

[serval:BIB_CE1082C6406A]

Psychopharmakologie – Pharmakopsychiatrie

Baumann Pierre, 2017. InFo NEUROLOGIE & PSYCHIATRIE, 15 (6) p. 20.

[serval:BIB_5E411CDC7185]

2016

[AGNP Psychiatric Drug Monitoring Consensus Guidelines: 2011] AGNP 精神科治疗药物监测共识指南 :2011

Hiemke Christoph, Baumann Pierre, Bergemann Niels, Conca Andreas, Dietmaier O., Egberts Karin, Fric M., Gerlach Manfred, Greiner Christine, Gründer Gerhard et al., 2016. Practical Pharmacy and Clinical Remedies, 19 (10) pp. 2 - 21.

[serval:BIB_1808C75864A9]

Clinical pharmacological management of polypharmacy in old age depression

Baumann Pierre, Greil Waldemar, 2016. pp. S39 dans 24th European Congress of Psychiatry / European Psychiatry.

[serval:BIB_41C214F8AAA7]

Consensus guideline for therapeutic drug monitoring in psychiatry (2004): Bibliometric analysis of citations for the period 2004-2011.

Schäfer Andreas, Hiemke Christoph, Baumann Pierre, 2016. Nordic Journal of Psychiatry, 70 (3) pp. 202-207. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A66B2F1AB081]

Creation of the Swiss group of pharmacogenomics and personalized therapy (SPT)

Mlakar Viad, Huezo Diaz Curtis Patricia, Baumann Pierre, Bühlmann Roland P., Meier-Abt Peter, Meyer Urs A., Ansari Marc, 2016. Schweizer Krebsbulletin 3 p. 264.

[URN][serval:BIB_3F468432D73C]

Création du Groupe Suisse de Pharmacogénomique et de Thérapie Personnalisée (SPT)

Baumann Pierre, Bühlmann Roland P., Jetter Alexander, Kupferschmidt Hugo, Meier-Abt Peter, Meyer Urs A., Ansari Marc, 2016. Pipette - Swiss Laboraty Medicine 3 pp. 17-18.

[serval:BIB_81E391775250]

The imipramine controversy. An official inqury of the clinical research activities (1946-1972) of Roland Kuhn (1912-2005)

Baumann Pierre, Ferrero François, 2016..

[serval:BIB_C5AD0EC8CA9F]

The present situation of psychopharmacology teaching suggests the need for a European curriculum

Baumann Pierre, Laux Gerd, 2016. pp. S62-S63 dans 24th European Congress of Psychiatry / European Psychiatry.

[serval:BIB_3A940526505E]

Une cardiopathie d'origine inhabituelle

Hungerbühler Philippe, Hedjal Ahmed, Girod Grégoire, Baumann Pierre, Plan Pierre Alain, 2016/01. Revue Médicale Suisse 502 pp. 148-151. Peer-reviewed.

[serval:BIB_EECC810271CB]

2015

Bestrebungen für ein europaweites Curriculum

Spies Marie, Baumann Pierre, Möller Hans-Jürgen, Bitter Istvàn, Laux Gerd, Kasper Siegfried, 2015. CliniCum Neuropsy 6 pp. 8-10.

[serval:BIB_8E5A1672C151]

Erratum zu: Nachruf auf Christian Müller (1921–2013)

Ciompi L.uc, Baumann Pierre, 2015. Der Nervenarzt, 86 (1) pp. 94-94.

[DOI][serval:BIB_2199800FA5A4]

Off Label Use of Other CNS Drugs (e.g.psychostimulants, Anticonvulsants, Lithium): Pro's and Con's

Baumann Pierre, 2015. p. 51 dans 23rd European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_FF41E1221F0C]

Therapeutisches Drug Monitoring von psychotropen Pharmaka in Kombination mit anderen Untersuchungen und Arzneimittelsicherheit

Baumann Pierre, Walder Alice, 2015. Psychiatrie & Neurologie 5 pp. 22-25.

[serval:BIB_B80A9BCC4045]

2014

A systematic review and meta-analysis of lithium augmentation of tricyclic and second generation antidepressants in major depression.

Nelson J.C., Baumann Pierre, Delucchi K., Joffe R., Katona C., 2014. Journal of Affective Disorders, 168 pp. 269-275. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_CA7C07CA45A2]

CYP2D6 : clinical implications in neuropsychiatry

Baumann Pierre, 2014. pp. 135-151 dans CYP2D6 : genetics, pharmacology and clinical relevance, Future Medicine.

[serval:BIB_53136C48F836]

CYP2D6 : genetics, pharmacology and clinical relevance

Baumann Pierre (eds.), 2014. 153, Future Medicine.

[serval:BIB_9F2684463132]

CYP2D6 : genetics, pharmacology and clinical relevance

Baumann Pierre, 2014. pp. 3-6 dans CYP2D6 : genetics, pharmacology and clinical relevance, Future Medicine.

[serval:BIB_E260FCF45BB6]

EPA-1471 - Polypharmacy in geriatric psychiatry: risks and management of pharmacokinetic interactions

Baumann Pierre, 2014. pp. Suppl. 1 dans 22nd European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_3F7C41AAA84B]

Linee guida della consensus conference dell'ANGP per il monitoraggio plasmatico dei farmaci (TDM) in psichiatria. Aggiornamento 2011 =AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011

Hiemke C., Baumann P., Bergemann N., Dietmaier O., Egberts K., Fric M., Gerlach M., Greiner C., Gründer G., Haen E. et al., 2014. Journal of Psychopathology, 20 (1) pp. 1-59.

[serval:BIB_437E3834E745]

Nachruf auf Christian Müller (1921-2013)

Ciompi L.uc, Baumann Pierre, 2014. Der Nervenarzt, 85 (9) pp. 1182-1183. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_A68296FF6BA9]

Pharmacovigilance en psychiatrie : données récentes

Baumann Pierre, 2014. pp. 661-662 dans 6ème Congrès Français de Psychiatrie, European Psychiatry. Peer-reviewed.

[URN][DOI][serval:BIB_19E5FF84A4DB]

The AMSP-project: Pharmacovigilance in psychiatry - Presentation, challenges and results

Baumann Pierre, 2014. p. 663 dans 6ème Congrès Français de Psychiatrie, European Psychiatry. Peer-reviewed.

[URN][DOI][serval:BIB_1EFC804B38C5]

Therapeutic Drug Monitoring

Baumann Pierre, 2014. pp. 1-9 dans Stolerman Ian P., Price Lawrence H. (eds.) Encyclopedia of Psychopharmacology, Springer.

[DOI][serval:BIB_C8A40F40B4A4]

Therapeutisches Drug-Monitoring in der Psychiatrie : Kurze Zusammenfassung des neuen Konsensuspapiers der Arbeitsgruppe TDM der AGNP [Therapeutic drug monitoring in psychiatry : A brief summary of the new consensus paper by the task force on TDM of the AGNP].

Gründer G., Baumann P., Conca A., Zernig G., Hiemke C., für die TDM-Gruppe der AGNP, 2014. Der Nervenarzt, 85 (7) pp. 847-855. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FB3856EE1487]

2013

Age and adverse drug reactions from psychopharmacological treatment: data from the AMSP drug surveillance programme in Switzerland.

Greil Waldemar, Häberle Anne, Schuhmann Thomas, Grohmann Renate, Baumann Pierre, 2013. Swiss Medical Weekly, 143 pp. w13772. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_7A2280A472CE]

Biologische Psychiatrie der Gegenwart : 3. Drei-Länder-Symposium für Biologische Psychiatrie Lausanne, September 1992

Baumann Pierre, Fleischhacker Wolfgang .W., Gaebel Wolfgang, Laux Gerd, Möller H.ans-Jürgen, Saletu Bernd, Woggon Brigitte (eds.), 2013. 804, Springer.

[DOI][serval:BIB_FA6B45E6815A]

Dosage plasmatique des medicaments antidépresseurs [Recommendations for therapeutic monitoring of antidepressants].

Baumann P., Rougemont M., Corruble E., Hiemke C., Groupe AGNP-DPM, 2013. Revue Médicale Suisse, 9 (377) pp. 577-586. Peer-reviewed.

[Pmid][serval:BIB_6434029EF865]

Psychopharmacologie et phases de la vie

Baumann Pierre, Planas Pedro, 2013. Info Neurologie & Psychiatrie, 11 (1) p. 51.

[serval:BIB_F988504C014D]

Psychopharmacotherapy after restrictive gastrointestinal surgery (Psychopharmakotherapie nach restriktiven gastrointestinalen Eingriffen. Fall bericht und Literaturübersicht)

Baumann Pierre, Tregouet Olivier, 2013. Psychopharmakotherapie, 20 (1) pp. 31-37.

[serval:BIB_DE27EBD62A76]

Psychopharmakotherapie nach restricktiven gastrointestinalen Eingriffen: Fallbericht und Literaturübersicht

Baumann Pierre, Trégouët Olivier, 2013. Psychopharmakotherapie, 20 (1) pp. 31-37. Peer-reviewed.

[serval:BIB_8109A62B221D]

Recommandations pour le monitoring plasmatique des médicaments antidépresseurs

Baumann Pierre, Rougemont Michael, Corruble Emmanuelle, Hiemke Christoph, 2013. Acta Psychiatrica Belgica, 113 (4) pp. 31-39.

[serval:BIB_7C4EF1D456A7]

Recommandations pour le monitoring plasmatique des médicaments antidépresseurs. Recommendations for therapeutic monitoring of antidepressants

Baumann Pierre, Rougemont Michael, Corruble Emmanuelle, Hiemke Christoph, Groupe AGNP-TDM, 2013. Acta Psychiatrica Belgica, 113 pp. 31-41.

[serval:BIB_37B4C221F368]

Transport Mechanisms of Tryptophan in Blood Cells, Nerve Cells, and at the Blood-Brain Barrier : Proceedings of the International Symposium, Prilly/Lausanne, Switzerland, July 6-7, 1978

Baumann Pierre (eds.), 2013. Journal of Neural Transmission 237, Springer.

[DOI][serval:BIB_204A7FC31D7E]

2012

Neue Empfehlungen für das Therapeutische Drug Monitoring in der Psychiatrie

Baumann Pierre, Hiemke Christoph, 2012/08. Pipette : Swiss Laboratory Medicine 4 pp. 15-16.

[serval:BIB_B0ED02567810]

AGNP-Konsensus-Leitlinien für therapeutisches Drug-Monitoring in der Psychiatrie: Update 2011

Hiemke Christoph, Baumann Pierre, Bergemann Niels, Conca Andreas, Dietmaier Otto, Egberts Karin, Fric Mirijam, Gerlach Manfred, Greiner Christine, Gründer Gerhard et al., 2012. Psychopharmakotherapie, 19 (3) pp. 91 - 122.

[serval:BIB_8BE053373635]

Az AGNP konszenzuson alapulo iranyelvi a terapias gyogyszerzint monitorozasahaoz a pszichiatriaban

Hiemke C., Baumann P., Bergemann N., Conca A., Dietmaier O., Egberts K., Fric M., Gerlach M., Greiner C., Gründer G. et al., 2012. Psychiatria Hungarica, 27 (Suppl. 1) pp. 7-64.

[serval:BIB_E7B4C6EA89D5]

Central Nervous System Drugs

Baumann Pierre, Hiemke Christoph, 2012. pp. 301-329 dans Anzenbacher Pavel, Zanger Ulrich M. (eds.) Metabolism of Drugs and other Xenobiotics, Wiley-VCH.

[serval:BIB_7F17DFE8AE15]

Citation of the AGNP consensus guidelines for therapeutic drug monitoring in psychiatry 2004 in the scientific literature 2004 to 2011

Schäfer A., Hiemke C., Baumann P., 2012. pp. 45 - A20 dans Psychotropic Drugs: Risks and Risk Management : Xth Congress of the Interdisciplinary TDM Task Force of the AGNP together with the Swiss Society for Pharmacovigilance in Psychiatry (SGAMSP) and the Swiss-Austrian Chapter of the International Society of Pharmacovigilance (ISoP), Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_66ABD207CB8F]

Clinical effectiveness, pharmacokinetics and pharmacogenetics of mirtazapine in depression

Jaquenoud Sirot E., Harenberg S., Vandel P., Mendonça Lima C.A., Perrenoud P., Kemmerling K., Zullino D.F., Hilleret H., Crettol S., Jonzier-Perey M. et al., 2012. pp. 45 - A10 dans Psychotropic Drugs: Risks and Risk Management : Xth Congress of the Interdisciplinary TDM Task Force of the AGNP together with the Swiss Society for Pharmacovigilance in Psychiatry (SGAMSP) and the Swiss-Austrian Chapter of the International Society of Pharmacovigilance (ISoP), Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_6D36408A49CA]

Cognitive efficacy of quetiapine in early-onset first-episode psychosis: a 12-week open label trial.

Urben Sébastien, Baumann Pierre, Barcellona Sandra, Hafil M., Preuss Ulrich, Peter-Favre Claire, Clarke Stéèphanie, Halfon Olivier, Holzer Laurent, 2012. Psychiatric Quarterly, 83 (3) pp. 311-324. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_84812EC41BE8]

Drug Interaction Probability Scale: Ein nützliches Instrument zur Abklärung von unerwünschten Arzneimittelwirkungen

Schuhmann T., Baumann P., 2012. InFo Neurologie und Psychiatrie, 10 (3) pp. 30-33.

[serval:BIB_EE3FB7A69489]

Flupentixol: relevance of stereoselective therapeutic drug monitoring.

Baumann P., Kirchherr H., Berney P., Hiemke C., 2012. Psychopharmacology, 221 (4) pp. 719-720. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_715A56F85544]

Matched case-control study: therapeutic drug monitoring in pharmacovigilance

Jaquenoud Sirot E., Stephan P.L., Eap C.B., van der Velden J.W., Baumann P., 2012. pp. 45 - A11 dans Psychotropic Drugs: Risks and Risk Management : Xth Congress of the Interdisciplinary TDM Task Force of the AGNP together with the Swiss Society for Pharmacovigilance in Psychiatry (SGAMSP) and the Swiss-Austrian Chapter of the International Society of Pharmacovigilance (ISoP), Pharmacopsychiatry. Peer-reviewed.

[DOI][WoS][serval:BIB_969E4BC34339]

Multicenter Study on the Clinical Effectiveness, Pharmacokinetics, and Pharmacogenetics of Mirtazapine in Depression.

Jaquenoud Sirot E.veline, Harenberg Sabine, Vandel Pierre, Lima Carlos .A., Perrenoud Patrick, Kemmerling Klaus, Zullino Daniele .F., Hilleret Henriette, Crettol Séverine, Jonzier-Perey Michèle et al., 2012. Journal of Clinical Psychopharmacology, 32 (5) pp. 622-629. Peer-reviewed.

[DOI][Pmid][serval:BIB_A42ABEFEA2B4]

Neue Empfehlungen für das Therapeutische Drug Monitoring: Bedeutung für die Arzneimittelsicherheit in der Psychiatrie

Baumann Pierre, Jaquenoud Sirot Eveline, Schwarz Markus, Hiemke Christoph, 2012. Info Neurologie & Psychiatrie : interdisziplinäre Fortbildung in der Neurologie, Psychiatrie und Psychotherapie, 10 (4) pp. 38-40.

[serval:BIB_6005482D8E38]

Pharmakokinetik, Pharmakogenetik und therapeutisches Drug Monitoring

Hiemke Christoph, Baumann Pierre, Stingl Julia, 2012. pp. 441 - 464 dans Gründer Gerhard, Benkert O.tto (eds.) Handbuch der psychiatrischen Pharmakotherapie, Springer.

[serval:BIB_4C0BDC816844]

Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.

Nikisch Georg, Baumann Pierre, Liu T., Mathé Alexander .A., 2012. International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (cinp), 15 (8) pp. 1051-1061. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_736E83FCC292]

SPCC TDM , a catalogie for analysis of therapeutic drug monitoring related contents in the drug prescription information

Ulrich Sven, Baumann Pierre, Conca Andreas, Kuss Hans-Joachim, Stieffenhofer V., Hiemke Christoph, 2012. pp. 319-328 dans Li X.-L., Ng S.-K. (eds.) Computational Knowledge Discovery for Bioinformatics Research, IGI-Global.

[serval:BIB_01587A7C5F97]

TDM in patients with substance related disorders

Havemann-Reinecke U., Bruenen S., Vincent P., Baumann P., Hiemke C., 2012. p. 1 dans 20th European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_A1581A386476]

The AGNP-TDM expert group consensus guidelines 2004 -therapeutic drug monitoring in psychiatry: Analysis of 199 citations (2004 - 2011)

Baumann P., Hiemke C., 2012. p. 1 dans 20th European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[URN][serval:BIB_040D4E3488FC]

Viktor von Weizsäcker et le national-socialisme [Viktor von Weizsäcker and national socialism].

Baumann P., 2012. Revue Médicale Suisse, 8 (333) pp. 655; discussion 656.

[Pmid][serval:BIB_CE0E5173F4BE]

2011

A new rating scale to evaluate the potential benefit of therapeutic drug monitoring

Bruenen S., Vincent P.D., Baumann P., Hiemke C., Havemann-Reinecke U., 2011. pp. 499-500 dans 12th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Therapeutic Drug Monitoring. Peer-reviewed.

[DOI][WoS][serval:BIB_3D37BCBBB4E9]

AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.

Hiemke C., Baumann P., Bergemann N., Conca A., Dietmaier O., Egberts K., Fric M., Gerlach M., Greiner C., Gründer G. et al., 2011. Pharmacopsychiatry, 44 (6) pp. 195-235. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_DF1A79714744]

Cytochrome P450 and ABCB1 genetics: association with quetiapine and norquetiapine plasma and cerebrospinal fluid concentrations and with clinical response in patients suffering from schizophrenia. A pilot study.

Nikisch Georg, Baumann Pierre, Oneda B., Kiessling B., Weisser H., Mathé A.A., Yoshitake T., Kehr J., Wiedemann G., Eap Chin B., 2011. Journal of Psychopharmacology, 25 (7) pp. 896-907. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_B7D93AB98992]

Die schweizerische Gesellschaft für Arzneimittelsicherheit in der Psychiatrie

Baumann Pierre, Angst Katrin, Brunner Sandra, Eich Philipp, Giachino Philipp, Hasler Gregor, Jaquenoud Sirot Eveline, Horvath Andreas, Keck Marin, Schuhmann Thomas et al., 2011. InFo Neurologie und Psychiatrie, 9 (1) p. 43.

[serval:BIB_992136C5A166]

Dosages plasmatiques de médicaments psychotropes à des fins thérapeutiques et tests pharmacogénétiques

Baumann Pierre, 2011. pp. 71-75 dans Calanca Aldo, Bryois Christian, Buclin Thierry (eds.) Vade-mecum de thérapqutique psychiatrique, Editions Médecine & Hygiène.

[serval:BIB_2DE9C4E31C1D]

Drug interactions in the treatment of Bipolar disorder

Baumann Pierre, 2011. p. 2028 dans 19th European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_471FE6DE1191]

Escitalopram in der klinischen Praxis: eine Erhebung von Praxiserfahrungen bei Patienten mit Depressionen und Angstörungen

Holsboer-Trachsler Edith, Baumann Pierre, Höck Paul, Hättenschwiler Josef, Jost Martin, Ramseier Fritz, Seifritz Erich, Nil Rico, 2011. Psychopharmakotherapie: Arzneimitteltherapie psychischer und neurologischer Erkrankungen, 18 (2) pp. 59-65.

[serval:BIB_9E70D095490C]

Multimorbidität und Polypharmazie in der Psychiatrie

Baumann Pierre, Greil Waldemar, 2011. pp. 58-59 dans 9. SGAMSP-Jahrestagung, InFo Neurologie und Psychiatrie.

[serval:BIB_3B7A8B6998BC]

Pharmacokinetics of psychotropic drugs - keys for treatments' improvements

Baumann Pierre, 2011. p. 1995 dans 19th European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[serval:BIB_ACC0E2992744]

Quetiapine in adolescents with non-affective psychotic disorders: an open-label trial.

Holzer L., Preuss U., Baumgartner L., Jaugey L., Urben S., Halfon O., Baumann P., 2011. Pharmacopsychiatry, 44 (3) pp. 87-95. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0006FD7FBE51]

Therapeutic drug monitoring for drugs used in the treatment of substance-related disorders: literature review using a therapeutic drug monitoring appropriateness rating scale.

Brünen S., Vincent P.D., Baumann P., Hiemke C., Havemann-Reinecke U., 2011. Therapeutic Drug Monitoring, 33 (5) pp. 561-572. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DAA099CD57B1]

Therapeutic drug monitoring in psychiatry.

Conca A., Baumann P., Hiemke C., 2011. Pharmacopsychiatry, 44 (6) pp. 193-194. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_782D63B9AEF6]

Therapeutic drug monitoring of drugs for treatment of substance-related disorders

Brünen S., Vincent P.D., Baumann P., Hiemke C., Havemann-Reinecke U., 2011. p. 13 dans 19th European Congress of Psychiatry, European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_CAD92C69F48E]

Vade-mecum de thérapeutique psychiatrique

Calanca Aldo (eds.), 2011., 10e éd. entièrement rév. et augm. 220, Médecine et hygiène.

[serval:BIB_95F488F0C04D]

Ventajas y desventajas del tratamiento de combinación con antipsicóticos. Reunión ECNP Consensus, marzo de 2008, Niza

Goodwin Guy, Fleischhacker Wolfgang, Arango Celso, Baumann Pierre, Davidson Michael, de Hert Marc, Falkai Peter, Kapur Shitij, Leucht Stefan, Licht Rasmus et al., 2011. Psiquiatría Biológica, 18 (2) pp. 55-67. Peer-reviewed.

[DOI][serval:BIB_8304F6454253]

Viktor von Weizsäcker et le national-socialisme : à propos de la Carte blanche du Pr Marco Vannotti : pathosophie ou l'objet de la médecine

Baumann Pierre, 2011. Revue médicale suisse 333 p. 655.

[serval:BIB_54528420E1C9]

2010

French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs.

Rougemont M., Ulrich S., Hiemke C., Corruble E., Baumann P., 2010/06. Fundamental & clinical pharmacology, 24 (3) pp. 377-384. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_DBA70501F744]

Burnout: eine Standortbestimmung

Nil Rico, Jacobshagen Nicola, Schächinger Hartmut, Baumann Pierre, Höck Paul, Hättenschwiler Josef, Ramseier Fritz, Seifritz Erich, Holsboer-Trachsler Edith, 2010. Schweizer Archiv für Neurologie und Psychiatrie = Archives Suisses de Neurologie et de Psychiatrie = Archivio Svizzero Di Neurologia E Psichiatria, 161 (2) pp. 72-77. Peer-reviewed.

[serval:BIB_3481C1A99F4A]

Pharmakogenetik

Baumann Pierre, 2010. pp. 337-351 dans Riederer Peter F., Laux Gerd (eds.) Grundlagen der Neuro-Psychopharmakologie : ein Therapiehandbuch, Springer.

[URN][serval:BIB_41EFC134766D]

Pharmakokinetik. Allgemeine Grundlagen

Müller Walter E., Hiemke Christoph, Baumann Pierre, 2010. pp. 289-303 dans Riederer Peter F., Laux Gerd (eds.) Grundlagen der Neuro-Psychopharmakologie : ein Therapiehandbuch, Springer.

[URN][serval:BIB_38756A51423B]

Professeur Alfred Bader: une nécrologie

Baumann Pierre, 2010. Schweizer Archiv für Neurologie und Psychiatrie = Archives Suisses de Neurologie et de Psychiatrie = Archivio Svizzero Di Neurologia E Psichiatria, 161 (1) pp. 46-47. Peer-reviewed.

[serval:BIB_839BA85D323D]

Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with l- and d,l-methadone.

Wedekind D., Jacobs S., Karg I., Luedecke C., Schneider U., Cimander K., Baumann P., Ruether E., Poser W., Havemann-Reinecke U., 2010. World Journal of Biological Psychiatry, 11 (2 Pt 2) pp. 390-399. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0871D0C2BA49]

Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.

Nikisch G., Baumann P., Wiedemann G., Kiessling B., Weisser H., Hertel A., Yoshitake T., Kehr J., Mathé A.A., 2010. Journal of Clinical Psychopharmacology, 30 (5) pp. 496-503. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7CD21C4AC442]

Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.

Nikisch G., Baumann P., Kiessling B., Reinert M., Wiedemann G., Kehr J., Mathé A.A., Piel M., Roesch F., Weisser H. et al., 2010. Journal of Psychiatric Research, 44 (12) pp. 754-759. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_473AC24F4018]

SPCCtdm, a Catalogue for analysis of Therapeutic drug Monitoring related Contents in the drug Prescription Information

Ulrich Sven, Baumann Pierre, Conca Andreas, Kuss Hans-Joachim, Stieffenhofer Viktoria, Hiemke Christoph, 2010. International Journal of Knowledge Discovery in Bioinformatics, 1 (2) pp. 1-11. Peer-reviewed.

[serval:BIB_DB52A2FAF903]

Spezielle Pharmakokinetik

Müller Walter E., Hiemke Christoph, Baumann Pierre, 2010. pp. 305-312 dans Riederer Peter F., Laux Gerd (eds.) Grundlagen der Neuro-Psychopharmakologie : ein Therapiehandbuch, Springer.

[URN][serval:BIB_C6C8895567AA]

Therapeutic Drug Monitoring

Baumann Pierre, 2010. pp. 1307-1313 dans Stolerman Ian P. (eds.) Encyclopedia of Psychopharmacology, Springer.

[serval:BIB_3A645548793B]

2009

ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.

Jaquenoud Sirot E., Knezevic B., Morena G.P., Harenberg S., Oneda B., Crettol S., Ansermot N., Baumann P., Eap C.B., 2009/08. Journal of clinical psychopharmacology, 29 (4) pp. 319-326. Peer-reviewed.

[URN][DOI][WoS][Pmid][serval:BIB_0F54C2F3BEB3]

Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.

Goodwin G., Fleischhacker W., Arango C., Baumann P., Davidson M., de Hert M., Falkai P., Kapur S., Leucht S., Licht R. et al., 2009. European Neuropsychopharmacology, 19 (7) pp. 520-532. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8EF223FB046E]

Cardiac left bundle branch block and pancytopenia in anorexia nervosa: higher risk with mirtazapine and pantoprazole? Case report.

Walder A., Baumann P., 2009. Pharmacopsychiatry, 42 (2) pp. 79-81. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_1B86426D8013]

Drug-induced Pisa syndrome under quetiapine.

Walder A., Greil W., Baumann P., 2009. Progress in neuro-psychopharmacology & biological psychiatry, 33 (7) pp. 1286-7. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8C63681B5E08]

La prescription off label dans le cadre des troubles bipolaires soulève des questions en pratique clinique

Baumann Pierre, 2009. PSY and PSY.

[serval:BIB_2B1DE9AF44E0]

Mood stabilizer therapy and pravastatin: higher risk for adverse skin reactions ?

Walder alice, Baumann Pierre, 2009. Acta Medica (Hradec Kralove), 52 (1) pp. 15-18. Peer-reviewed.

[serval:BIB_AAC25B70403A]

Nachruf : Prof. Alfred Bader = Nécrologie : Professeur Alfred Bader

Baumann Pierre, 2009. Psy and Psy 2 p. 22.

[serval:BIB_DCE0573363EA]

Polymedication in elderly psychiatric patients suffering from comorbidities: risks for pharmacokinetic interactions with clinical consequences

Baumann Pierre, 2009/01., 17th European congress of psychiatry, January 24-28, 2009, Lisbon, Portugal pp. S48-03 dans , European psychiatry. Peer-reviewed.

[serval:BIB_A6FCDB0D8658]

Prescription off-label et troubles bipolaires: questions en pratique clinique

Baumann Pierre, 2009. Psy & Psy 2 pp. 10-11.

[serval:BIB_762F7B4D8F21]

Psychopharmaka - Off-Label-Use (1/2)

Baumann Pierre, Voirol Pierre, 2009. PharmaJournal, 22 pp. 4-7.

[serval:BIB_B2406D9B6FCB]

Psychopharmaka - Off-Label-Use (2/2)

Baumann Pierre, Voirol Pierre, 2009. PharmaJournal, 23 pp. 4-6.

[serval:BIB_B7EF4445F9F5]

Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour

Lind Anna-Britta, Reis Margareta, Bengtsson Finn, Jonzier Perey Michèle, Powell Golay Kerry, Ahlner Johan, Baumann Pierre, Dahl Marja-Liisa, 2009. Clinical Pharmacokinetics, 48 (1) pp. 63-70. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_7CFD46C09739]

Therapeutic drug monitoring and pharmacogenetic tests in pharmacovigilance - when and what ?

Jaquenoud Sirot E., Baumann P., 2009/01., 17th European congress of psychiatry, January 24-28, 2009, Lisbon, Portugal pp. S20-02 dans , European Psychiatry. Peer-reviewed.

[serval:BIB_D1F4EA0F09D6]

Utilisation «off label» des médicaments psychotropes (1/2)

Baumann Pierre, Voirol Pierre, 2009. PharmaJournal, 22 pp. 7-10.

[URN][serval:BIB_012C292BD483]

Utilisation «off label» des médicaments psychotropes (2/2)

Baumann Pierre, Voirol Pierre, 2009. PharmaJournal, 23 pp. 8-10.

[serval:BIB_8019366AB3C9]

2008

Dysfonctions sexuelles induites par les antidépresseurs et les antipsychotiques et leurs traitements [Sexual dysfunctions induced by antidepressants and antipsychotics]

Martin-Du P.R., Baumann P., 2008/03/26. Revue medicale suisse, 4 (150) pp. 758-762. Peer-reviewed.

[Pmid][serval:BIB_A0273AA36C15]

"Therapeutic drug monitoring" in Epileptologie und Psychiatrie [Therapeutic drug monitoring in epileptology and psychiatry]

Brandt Christian, Baumann Pierre, Hiemke Christoph, May T.W., Rambeck B., Pohlmann-Eden B., 2008. Der Nervenarzt, 79 (2) pp. 167-174. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_06293C1C756E]

ABCB1 and cytochromes P450 genotypes and phenotypes: influence on clozapine plasma concentrations

Jaquenoud Sirot Eveline, Knezevic B., Perla Morena Gina, Baumann Pierre, Eap Chin Bin, 2008. pp. e465 dans , Canadian Journal of Clinical Pharmacology = Journal canadien de pharmacologie clinique. Peer-reviewed.

[serval:BIB_8F425FA35787]

Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study.

Nikisch G., Eap C.B., Baumann P., 2008. Pharmacological research, 58 (5-6) pp. 344-347. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9AD9C8C6AC8A]

Dysfonctions sexuelles induites par les antidépresseurs et les antipsychotiques et leurs traitements

Martin-Du Pan Rémy, Baumann Pierre, 2008. Revue médicale suisse, 4 (150) pp. 758-762. Peer-reviewed.

[serval:BIB_5C88F5FB7E84]

Effect of the NMDA-receptor antagonist dextromethorphan in infant rat pneumococcal meningitis.

Sellner J., Ringer R., Baumann P., Perey M.J., Schmitt B., Leib S.L., 2008. Current Drug metabolism, 9 (1) pp. 83-88. Peer-reviewed.

[WoS][Pmid][serval:BIB_39996DF3240B]

Gestörte Chronobiologie begüngstigt Depressionen: Resynchronisierung als Wirkprinzip

Baumann Pierre, 2008. Leading Opinions. Neurologie und Psychiatrie, 8 (4) pp. 8-10.

[serval:BIB_B70967D5C6B2]

Gestörte Chronobiologie begünstigt Depressionen. Resynchronisierung als Wirkprinzip

Baumann Pierre, 2008. Leading Opinions Neurologie & Psychiatrie, 8 (4) pp. 8-10.

[serval:BIB_A17AA742F702]

Increased creatinine kinase and rhabdomyolysis in anorexia nervosa.

Walder A., Baumann P., 2008. International Journal of Eating Disorders, 41 (8) pp. 766-767. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_213E3145393B]

Metabolism of psychotropic drugs in the human brain: significance for therapeutic drug monitoring ?

Baumann Pierre, 2008. dans Pharmacopsychiatrie, Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_BA3C221ED9A4]

Nutzen und Aktualität der Fachinformationen für das therapeutische Drug-Monitoring von Psychopharmaka: ein Vergleich mit der Evidenz aus der Literatur

Ulrich Sven, Laux Gerd, Müller-Oerlinghausen Bruno, Havemann-Reinecke Ursula, Riederer Peter, Zernig Gerald, Baumann Pierre, Hiemke Christoph, 2008. Psychopharmakotherapie, 15 (2) pp. 67-74. Peer-reviewed.

[WoS][serval:BIB_58C2F2F468D1]

Off-label utilization of antidepressants.

Zullino D.F., Schwartz B., Bilancioni R., Baumann P., 2008. Acta Medica (hradec Králové) / Universitas Carolina, Facultas Medica Hradec Králové, 51 (1) pp. 19-24. Peer-reviewed.

[Pmid][serval:BIB_F69E77235432]

Pharmacogenetics of clozapine: in vivo role of cytochrome P450 isoforms and P-Glycoprotein

Jaquenoud Sirot Eveline, Knezevic B., Perla Morena Gina, Baumann Pierre, Eap Chin Bin, 2008. dans Pharmacopsychiatry, Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_7BD695DD2CB3]

Pharmacovigilance in psychiatry: pharmacogenetic tests and therapeutic drug monitoring are promising tools

Baumann P., 2008. Expert Review of Clinical Pharmacology, 1 (2) pp. 183-185. Peer-reviewed.

[DOI][Pmid][serval:BIB_AF09DBAABDCE]

Pharmakokinetik, Pharmakogenetik und therapeutisches Drug Monitoring

Hiemke C., Baumann P., 2008. pp. 375-397 dans Holsboer Florian, Gründer Gerhard, Benkert Otto (eds.) Handbuch der Psychopharmakotherapie, Springer.

[serval:BIB_A4F7EC703FA2]

Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with l- and d,l-methadone.

Wedekind D., Jacobs S., Karg I., Luedecke C., Schneider U., Cimander K., Baumann P., Ruether E., Poser W., Havemann-Reinecke U., 2008. World Journal of Biological Psychiatry, 9 pp. 1-10. Peer-reviewed.

[DOI][Pmid][serval:BIB_14D1FF1E78F1]

Purpura and ecchymosis under carbamazepine, chloral hydrate and melitracen-flupentixol.

Walder A., Greil W., Baumann P., 2008. European Journal of Dermatology, 18 (1) pp. 103-104. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0C99B0046EBA]

Quetiapine in adolescents with psychosis: a 12 weeks open label trial

Holzer Laurent, Preuss Ulrich, Clarke Stephanie, Halfon Olivier, Baumann Pierre, 2008. p. 162 dans Schizophrenia Research, Schizophrenia Research. Peer-reviewed.

[DOI][serval:BIB_08A52DBB190A]

Spezielle Arzneimittelinteraktionen

Hiemke C., Baumann P., 2008. pp. 1127-1144 dans Holsboer Florian, Gründer Gerhard, Benkert Otto (eds.) Handbuch der Psychopharmakotherapie, Springer.

[serval:BIB_B5DBE509D612]

TDMplus: the combination of TDM, check for drug interactions and genotyping

Jaquenoud Sirot Eveline, Baumann Pierre, 2008. pp. A19 dans 5th Regensburg Symposium on Clinical Pharmacology - of Therapeutical Drug Monitoring - 8th Workshop of the TDM Workgroup of AGNP, Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_11176496D021]

Terapia antidepressantami i dugie metodi letchenja depressivnich rasstoist

Sartorius Norman, Baghai Thomas C., Baldwin David S., Barrett Barbara, Brand Ursula, Fleischhacker Wolfgang, Goodwin Guy, Grunze Heinz, Knapp Martin, Leonard Brian E. et al., 2008. 215, Rossiiskoje obchestvo pcichjatrov.

[serval:BIB_58BDAC325BF9]

Text analysis and drug analysis: therapeutic drug monitoring in the prescription information

Ulrich Sven, Hiemke Christoph, Conca Antoinette, Kuss Hans-Joachim, Tatusch V., Baumann Pierre, 2008. p. 216 dans , Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_3C5CD96E702B]

The AGNP-TDM expert consensus guidelines 2004: a promising start !

Baumann Pierre, 2008. dans Pharmacopsychiatrie, Pharmacopsychiatry. Peer-reviewed.

[DOI][serval:BIB_937AB4D49A96]

Therapeutic monitoring of psychotropic drugs to improve compliance

Baumann Pierre, 2008. p. 86 dans International Journal of Neuropsychopharmacology, International Journal of Neuropsychopharmacology. Peer-reviewed.

[DOI][serval:BIB_500857235122]

Traitement pharmacologique de la schizophrénie: évaluation comparative de la qualité des recommandations de pratique clinique [Comparative evaluation of clinical practice guidelines for the treatment of schizophrenia]

Delessert D., Pomini V., Grasset F., Baumann P., 2008. L'Encéphale, 34 (1) pp. 93-100. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_0971D5E3C788]

Wie wirksam sind Antidepressiva ?: zur Bedeutung von Plasmakonzentrations-Wirksamkeits-Studien

Hiemke Christoph, Ulrich Sven, Baumann Pierre, Broich Karl, Conca Andreas, Havemann-Reinecke Ursula, Gerlach Manfred, Haen Ekkehard, Laux Gerd, Müller-Oerlinghausen Bruno et al., 2008. Psychopharmakotherapie, 15 (4) pp. 162-163. Peer-reviewed.

[WoS][serval:BIB_C188CF3EFA65]

2007

Dépression: le point sur les traitements psychopharma- cologiques [Pharmacotherapy of depression: recent developments]

Baumann P., 2007/09/19. Revue medicale suisse, 3 (125) pp. 2079-2080,2083-2084. Peer-reviewed.

[Pmid][serval:BIB_2EEBAF4C185A]

Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.

Sartorius N., Baghai T.C., Baldwin D.S., Barrett B., Brand U., Fleischhacker W., Goodwin G., Grunze H., Knapp M., Leonard B.E. et al., 2007. International Journal of Neuropsychopharmacology, 10 (Suppl. 1) pp. S1-S207. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_157523158DCC]

Begünstigen Antidepressiva die Suizidalität und die Suizidrate von Depressiven?

Hättenschwiler Josef, Baumann Pierre, Hatzinger Martin, Höck Paul, Holsboer-Trachsler Edith, Jost Martin, Nil Rico, Ramseier Fritz, Seifritz Erich, Zullino Daniele et al., 2007. Schweiz Med Forum, 7 pp. 757-764.

[serval:BIB_CB46E41BD043]

Efficacy and tolerability of quetiapine in cluster B personality disorder: an open-label study

Le Bloc'h Yves, Baumann Pierre, Stigler Michael, Eap Chin-Bin, Zullino Daniele Fabio, 2007. International Journal of Psychiatry in Clinical Practice, 11 (2) pp. 123-128. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_F36241EE32C5]

Les antidépresseurs favorisent-ils la suicidalité et le suicide chez les individus dépressifs?

Hättenschwiller Joseph, Baumann Pierre, Hatzinger Martin, Höck Paul, Holsboer-Trachsler Edith, Jost Martin, Nil Rico, Ramseier Fritz, Seifritz Erich, Zullino Daniele et al., 2007. Swiss Medical Forum = Forum Médical Suisse, 7 (37) pp. 757-764. Peer-reviewed.

[serval:BIB_0D50C724AE70]

Médicaments et autres traitements des troubles dépressifs : revue technique des preuves scientifiques réalisée par un groupe de travail du CINP [Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence].

Baghai Thomas C., Baldwin David S., Barret Barbara, Bauman Pierre, Ghalib Kareem, Goodwin Guy, Grunze Heinz, Knapp Martin, Leonard Brian E., Markowitz John C. et al., 2007/01/01. 526, CINP Task Force.

[serval:BIB_12D1B854605E]

Pharmacokinetic influences on treatment of the elderly

Baumann Pierre, 2007. pp. 296-340 dans , International Journal of Psychiatry in Clinical Practice. Peer-reviewed.

[DOI][serval:BIB_D8C69186098D]

Problem solving in psychopharmacotherapy using pharmacokinetic and pharmacogenetic tests

Baumann Pierre, Jaquenoud Sirot Eveline, Hiemke Christoph, Bengtsson Finn, 2007. p. 96 dans , European Psychiatry. Peer-reviewed.

[DOI][WoS][serval:BIB_3AA3CB95322A]

Recommandations de pratique clinique dans la schizophrénie: de la théorie à la mise en application = Clinical practice guidelines for the treatment of schizophrenia: from theory to practice

Delessert D., Pomini V., Grasset F., Baumann P., 2007. Encéphale, 33 (6) pp. 902-910. Peer-reviewed.

[DOI][WoS][serval:BIB_20A3F982AC9A]

Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role?

Mathé A.A., Husum H., El Khoury A., Jiménez-Vasquez P., Gruber S.H., Wörtwein G., Nikisch G., Baumann P., Agren H., Andersson W. et al., 2007. Physiology and Behavior, 92 (1-2) pp. 226-231. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_9A0AE7AC878C]

Selective serotonin reuptake inhibitors in adolescent depression still controversial

Holzer L., Baumann P., 2007. Journal of clinical psychopharmacology, 27 (3) pp. 325-6; author reply 326. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_AD4724F82DF1]

Therapeutic drug monitoring of antidepressants--clinical aspects

Laux G., Baumann Pierre, Hiemke C., T. D. M. group of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie, 2007. J Neural Transm Suppl 72 pp. 261-7.

[Pmid][serval:BIB_78F2D0F61EA7]

Value and actuality of the prescription information for therapeutic drug monitoring of psychopharmaceuticals: a comparison with the medico-scientific evidence

Ulrich Sven, Hiemke Christoph, Laux Gerd, Müller-Oerlinghausen Bruno, Havemann-Reinecke U., Riederer Peter, Zernig Gerald, Baumann Pierre, 2007. Pharmacopsychiatry, 40 (3) pp. 121-127. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_8413DCBFD575]

2006

Psychotropic drug prescriptions in hospitalized elderly psychiatric patients: comparison with adult psychiatric patients

ZULLINO Daniele F., REYNAUD Gilbert, DE MENDONCA LIMA Carlos Augusto, BAUMANN Pierre, 2006/06. Psychogeriatrics, 6 (2) pp. 68-73. Peer-reviewed.

[DOI][serval:BIB_E666B3DB4A61]

Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activity

Stephan P.L., Jaquenoud Sirot E., Mueller B., Eap C.B., Baumann P., 2006. Pharmacopsychiatry, 39 (4) pp. 150-2. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FD70580355FC]

Apport de la pharmacogénétique dans le traitement médicamenteux des addictions : l'exemple de la méthadone

Eap C.B., Baumann P., 2006. pp. 65-70 dans Suchtforschung des BAG. Recherches de l'OFSP en matière de dépendances 2002-03, Bundesamt für Gesundheit.

[URN][serval:BIB_0953690D575B]

Clinical relevance of TDM of SSRIs

Schwarz Markus J., Hiemke Christoph, Baumann Pierre, 2006. Therapeutic Drug Monitoring, 28 (5) pp. 716-717. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_993ADB1C0E9A]

Dose-dependent venlafaxine-induced hair loss

Jaquenoud Sirot Eveline, Etzensberger M., Eap Chin-Bin, Baumann Pierre, 2006. p. 939 dans , Drug Safety. Peer-reviewed.

[serval:BIB_1AEB8C64710D]

Drug monographs on drugs which are frequently analysed in the context of Therapeutic Drug Monitoring = Arzneimittel-Monographien für Medikamente, die regelmässig im Rahmen des Therapeutic Drug Monitorings analysiert werden

Rentsch Katharina, Baumann Pierre, Fathi Marc, Grignaschi Nathalie, Magnin Jean-Luc, Thormann Wolfgang, Todesco Liliane, Wenk Markus, Werner Dominique, 2006. LaboratoriumsMedizin = Journal of Laboratory Medicine, 30 (6) pp. 443-452. Peer-reviewed.

[URN][DOI][serval:BIB_2534A7E3A40F]

Epidemiology of major depression: how is the view changing ?

Schlaepfer T.E., Baumann Pierre, 2006. pp. 13-14 dans , Parkinsonism and Related Disorders. Peer-reviewed.

[serval:BIB_BE1AEA2F628C]

Epileptiform seizure after sertraline treatment in an adolescent experiencing obsessive-compulsive disorder and presenting a rare pharmacogenetic status.

Baumann P., Barbe R., Vabre-Bogdalova A., Garran E., Crettol S., Eap C.B., 2006. Journal of clinical psychopharmacology, 26 (6) pp. 679-81. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_C2275B85B7A2]

Epileptiform seizure following sertraline treatment in an adolescent suffering from obsessive compulsive disorder and presenting a rare pharmacogenetic status

Baumann Pierre, Barbe R., Vabre-Bogdalova A., Garran E., Crettol Séverine, Eap Chin B., 2006. Journal of Clinical Psychopharmacology, 26 (6) pp. 679-681.

[serval:BIB_904321AD6133]

Le dosage plasmatique des médicaments psychotropes à des fins thérapeutiques: recommandations du groupe d'experts AGNP-TDM

Baumann Pierre, Hiemke Christoph, Ulrich Sven, Eckermann Gabriel, Kuss H.L., Laux Gerd, Muller-Oerlingenhausen B., Rao Marie Luise, Riederer Peter, Zernig Gerald, 2006. Revue médicale suisse, 2 (67) pp. 1413-1418. Peer-reviewed.

[Pmid][serval:BIB_2D16AD94CF56]

Mirtazapine enantiomers in blood and cerebrospinal fluid

Baumann Pierre, Jonzier Perey Michèle, Paus Erik, Nikisch Georg, 2006. Neuropsychobiology, 54 (3) pp. 179-181. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_30C59CF45DF9]

Neuropeptide Y (NPY) and corticotropinreleasing hormone (CRH) in human CSF and in brain of animal models of depression

Mathé Aleksander A., Agren Hans, Andersson Weronica, Baumann Pierre, El Khoury Aram, Gruber Susanne H.M., Jiménez-Vasquez Patricia, Nikisch Georg, Wörtwein Gitta, 2006. p. 74 dans , International Journal of Neuropsychopharmacology. Peer-reviewed.

[DOI][serval:BIB_034843468787]

Neuropeptides in human cerebrospinal fluid and in brains of animal models of depression - effects of treatment

Mathé Aleksander A., Nikisch Georg, Agren Hans, Baumann Pierre, El Khoury Aram, Gruber Susanne H.M., Husum Henriette, Jiménez-Vasquez Patricia, Wörtwein Gitta, Andersson Weronica et al., 2006. pp. 308-309 dans , European Neuropsychopharmacology. Peer-reviewed.

[serval:BIB_3700339B02D1]

Off-label utilization of antipsychotics

Zullino Daniele Fabio, Bilancioni Romain, Conus Philippe, Schwartz B., Khazaal Yasser, Baumann Pierre, 2006. South African Psychiatry Review, 9 (1) pp. 38-43. Peer-reviewed.

[serval:BIB_A3676EFD6441]

Pharmacokinetics and interaction in old age

Baumann Pierre, 2006. p. 319 dans , International Journal of Psychiatry in Clinical Practice. Peer-reviewed.

[DOI][serval:BIB_5BD8AA024F40]

Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening.

Bonsack C., Camus D., Kaufmann N., Aubert A.C., Besson J., Baumann P., Borgeat F., Gillet M., Eap C.B., 2006. Addictive behaviors, 31 (7) pp. 1252-8. Peer-reviewed.

[DOI][WoS][Pmid][serval:BIB_FD2258F80A77]

Problem solving in psychopharmacotherapy using pharmacokinetic and pharmacogenetic tests

Baumann Pierre, 2006. p. 64 dans , European Psychiatry. Peer-reviewed.

[DOI][serval:BIB_C0085B5111A4]

Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11

Contact
Annuaires

Informations légales
Plan du site
Edition